Inventaire - your friends and communities are your best library

Armed and targeted measles virus for chemovirotherapy of pancreatic cancer.

author

Mathias F Leber

published in: Cancer Gene Therapy

date of publication: 2011-06-24

language: English

main subject: measles

Cites articles 54

Date

Title

Authors

2010-04-29

Pancreatic cancer
2010-08

Oncolytic measles viruses encoding interferon beta and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy

David Dingli
2010-08-05

Mantle cell lymphoma salvage regimen: synergy between a reprogrammed oncolytic virus and two chemotherapeutics

Koon-Chu Yaiw
2009-07-09

High-throughput detection and multiplex identification of cell contaminations
2009-07-01

Prostate-specific membrane antigen retargeted measles virotherapy for the treatment of prostate cancer

Stephen J. Russell, Kah-Whye Peng
2009-04-03

Development of gene therapy in association with clinically used cytotoxic deoxynucleoside analogues

Charles Dumontet, Lars Jordheim
2009-01-01

Engineered measles virus as a novel oncolytic therapy against prostate cancer

Stephen J. Russell, Roberto Cattaneo, Evanthia Galanis
2009-01-01

Improvement of gemcitabine-based therapy of pancreatic carcinoma by means of oncolytic parvovirus H-1PV.
2008

Cancer statistics, 2008

Michael Thun
2008-04-14

Targeting gene therapy for hepatocarcinoma cells with the E. coli purine nucleoside phosphorylase suicide gene system directed by a chimeric alpha-fetoprotein promoter

Pei-yuan Li
2008-07-29

Interleukin-13 displaying retargeted oncolytic measles virus strains have significant activity against gliomas with improved specificity

Stephen J. Russell, Evanthia Galanis
2007-05-01

Treatment options for hepatobiliary and pancreatic cancer

Gregory J Gores, Steven R Alberts
2007-07-01

Targeting of tumor cells expressing the prostate stem cell antigen (PSCA) using genetically engineered T-cells

Michael Bachmann, Achim Temme
2007-05-20

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group
2007-03-23

Oncolytic viruses in cancer therapy
2007-08-21

An immunocompetent murine model for oncolysis with an armed and targeted measles virus

Christoph Springfeld, Roberto Cattaneo
2007-11-01

Lymphoma chemovirotherapy: CD20-targeted and convertase-armed measles virus can synergize with fludarabine

Roberto Cattaneo
2007-01-12

Delivery of replication-competent retrovirus expressing Escherichia coli purine nucleoside phosphorylase increases the metabolism of the prodrug, fludarabine phosphate and suppresses the growth of bladder tumor xenografts

Bernard H Bochner, Eiji Kikuchi
2006-06-01

Pharmacogenetics of anticancer drug sensitivity in pancreatic cancer

Romano Danesi
2006-12-01

Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma.

Stephen J. Russell, Kah-Whye Peng, Mark J. Federspiel, Rae M Myers, Suzanne M Greiner
2006-04-27

A measles virus vaccine strain derivative as a novel oncolytic agent against breast cancer

Stephen J. Russell, Evanthia Galanis, Charles Erlichman, James N Ingle
2005-01-01

PNP anticancer gene therapy

Steven E Ealick
2005-08

Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer

Markus Büchler, Helmut Friess, Moritz N Wente, Thomas Giese, Howard A Reber, Oscar J Hines
2005-01-01

Effective gene therapy of biliary tract cancers by a conditionally replicative adenovirus expressing uracil phosphoribosyltransferase: significance of timing of 5-fluorouracil administration

Takehide Murata, Kazunari K Yokoyama, Hideyo Ugai
2005-03-01

Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 1 inhibits transforming growth factor-beta signaling
2005-01-30

Rescue and propagation of fully retargeted oncolytic measles viruses

Stephen J. Russell, Kah-Whye Peng, Suzanne M Greiner
2005-06-01

Expression and localization of human multidrug resistance protein (ABCC) family members in pancreatic carcinoma

Anne T. Nies, Helmut Friess, Markus Büchler, Marc E Martignoni, Mark Hartel
2004-09-01

Excellent in vivo bystander activity of fludarabine phosphate against human glioma xenografts that express the escherichia coli purine nucleoside phosphorylase gene

Eric Sorscher
2004-11-01

Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirus

Rosetta Martiniello-Wilks
2004-08-01

Characterization of a gemcitabine-resistant murine leukemic cell line: reversion of in vitro resistance by a mononucleotide prodrug

Lars Jordheim, John R. Mackey, Charles Dumontet
2004-07-01

High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus

Stephen J. Russell, Kah-Whye Peng
2004-02-15

Antibody-targeted cell fusion

Roberto Cattaneo, Stephen J. Russell, Kah-Whye Peng, Sompong Vongpunsawad

Article - wd:Q37557813

Welcome to Inventaire

the library of your friends and communities

learn more